on 19 Sep 2023
Last Applicant/ Owned by
251 Ballardvale Street
Wilmington
MA
01887
Serial Number
97376854 filed on 22nd Apr 2022
Registration Number
7171334 registered on 19th Sep 2023
Correspondent Address
Joseph V. Myers III
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying,Read More
Pharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using artificial intelligence; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using machine learning; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using artificial intelligence; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using machine learning; Pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing chemical lead series or lead compounds via software using artificial intelligence, machine learning, computational modeling, DNA-encoded library screening platform, high-throughput screening, medicinal chemistry, ADME, biology, pharmacology and/or non-GLP safety testing
27th Apr 2022
27th Apr 2022
No 97376854
No Service Mark
No 057670
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Sep 2023 | REGISTERED-PRINCIPAL REGISTER |
| 19th Sep 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 17th Aug 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 16th Aug 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 18th Jul 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Jul 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 21st Jun 2023 | TEAS STATEMENT OF USE RECEIVED |
| 21st Jun 2023 | USE AMENDMENT FILED |
| 31st Jan 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 06th Dec 2022 | PUBLISHED FOR OPPOSITION |
